-
2024 COMB丨Dr. Songqing Ye: Exploring the Development of CDK4/6 Inhibitors, ADCs, and Immunotherapy in Early-Stage Breast Cancer
From August 2-4, 2024, the 7th Oncology Precision Diagnosis and Treatment Conference and the 10th Breast Cancer Individualized Treatment Conference (COMB), organized by the China Cancer Foundation and Beijing Breast Disease Prevention Society, was grandly held in Beijing. The conference brought together the latest advances in individualized precision treatment for breast cancer in China, providing…
-
2024 COMB丨Dr. Yanxia Zhao: Comprehensive Considerations for Radiotherapy Exemption and Hypofractionated Radiotherapy in Clinical Practice
From August 2-4, 2024, the 7th Oncology Precision Diagnosis and Treatment Conference and the 10th Breast Cancer Individualized Treatment Conference (COMB), organized by the China Cancer Foundation and Beijing Breast Disease Prevention Society, was grandly held in Beijing. The conference gathered the latest advancements in individualized precision treatment for breast cancer in China and provided…
-
AIDS Interview | Enhancing Immune Protection for HIV-Positive Individuals: Tailored Vaccination Strategies
In the field of AIDS prevention and treatment, tailored immunization strategies for HIV-positive individuals are becoming crucial for improving patients’ quality of life and prolonging their lifespan. At the 25th International AIDS Conference (AIDS 2024), Dr. Anna Maria Geretti from the Institute of Infection and Global Health, University of Liverpool presented an insightful report on…
-
AIDS Interview | Doxycycline Pre-Exposure Prophylaxis Shows Significant Effects in Preventing STIs Among HIV-Positive Individuals
At the 25th International AIDS Conference, a study led by Dr. Troy Grennan from the British Columbia University and the Canadian Centre for Disease Control revealed the astonishing effectiveness of doxycycline pre-exposure prophylaxis (DoxyPrEP) in reducing the incidence of bacterial sexually transmitted infections (STIs) among HIV-positive men who have sex with men. The study found…
-
Dr. Mark Muthiah: Exploration of Liver Fibrosis Reversal and Patient Clinical Management
Recently, the Combined GlHep&SHC 2024 was held in Singapore. This conference brings together elite scholars in the field of liver disease from around the world to discuss the latest developments, challenges, and opportunities in liver disease. Hepatology Digest invited Dr. Mark Muthiah from the National University Hospital, Singapore to conduct in-depth discussions on issues related…
-
Dr Ken Liu: New Technology for Hepatocellular Carcinoma Detection
The Combined GlHep&SHC 2024 was recently held in Singapore. This conference brings together elite scholars in the field of liver disease from around the world to discuss the latest developments, challenges, and opportunities in liver disease. Liver cancer is the third leading cause of cancer death worldwide, and hepatocellular carcinoma (HCC) is the most common…
-
Building a Health Defense Line, Focusing on China Anemia Day on August 18th: Caring for the Source of Life, Starting with Understanding Anemia
Understanding Anemia: The Invisible Health Challenge Anemia, in simple terms, refers to a reduction in the peripheral blood red blood cell (RBC) count below the normal range, a common clinical…
-
International Lung Cancer Conferenc | Dr. Huijuan Wang Reviews Perioperative Treatment Advances in NSCLC
The perioperative treatment of early-stage non-small cell lung cancer (NSCLC) has now entered the era of precision-targeted therapy and immunotherapy. At the NSCLC Medical Treatment Session of the International Lung Cancer Conference (CLC 2024) held from August 9-11, Dr. Huijuan Wang from Henan Cancer Hospital delivered a keynote speech titled “Advances in Perioperative Treatment of…
Connecting Medical Expertise through Media